Although TDK needs to invest aggressively to meet the requirements of the robust demand of auto MLCC, the company focuses on delivering stable dividends to shareholders. TDK’s three-year average ...
The implant demonstrates stability and consistent drug release, supporting further analytical testing and development SARASOTA, FL, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ( ...